Department of Colorectal Surgery, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510655, Guangdong, China.
Department of General Surgery, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510655, Guangdong, China.
BMC Cancer. 2023 Jul 18;23(1):675. doi: 10.1186/s12885-023-11114-8.
Current guidelines only propose the importance of perineural invasion(PNI) on prognosis in stage II colon cancer. However, the prognostic value of PNI in other stages of colorectal cancer (CRC) is ambiguous.
This single-center retrospective cohort study included 3485 CRC patients who underwent primary colorectal resection between January 2013 and December 2016 at the Sixth Affiliated Hospital of Sun Yat-sen University. Associations of PNI with overall survival (OS) and disease-free survival (DFS) were evaluated using multivariable Cox proportional hazards regression models. In addition, interaction analyses were performed to explore the prognostic effects of PNI in different clinical subgroups.
After median follow-up of 61.9 months, we found PNI was associated with poorer OS (adjusted hazard ratio [aHR], 1.290; 95% CI, 1.087-1.531) and DFS (aHR, 1.397; 95% CI, 1.207-1.617), irrespective of tumor stage. Interestingly, the weight of PNI was found second only to incomplete resection in the nomogram for risk factors of OS and DFS in stage II CRC patients. Moreover, OS and DFS were insignificantly different between stage II patients with PNI and stage III patients (both P > 0.05). PNI was found to be an independent prognostic factor of DFS in stage III CRC (aHR: 1.514; 95% CI, 1.211-1.892) as well. Finally, the adverse effect of PNI on OS was more significant in female, early-onset, and diabetes-negative patients than in their counterparts (interaction P = 0.0213, 0.0280, and 0.0186, respectively).
PNI was an important prognostic factor in CRC, more than in stage II. The survival of patients with stage II combined with perineural invasion is similar with those with stage III. PNI in stage III CRC also suggests a worse survival.
目前的指南仅提出了神经周围侵犯(PNI)对 II 期结肠癌预后的重要性。然而,PNI 在结直肠癌(CRC)其他分期中的预后价值尚不清楚。
本单中心回顾性队列研究纳入了 2013 年 1 月至 2016 年 12 月在中山大学附属第六医院接受原发性结直肠切除术的 3485 例 CRC 患者。使用多变量 Cox 比例风险回归模型评估 PNI 与总生存(OS)和无病生存(DFS)的关系。此外,还进行了交互分析以探讨 PNI 在不同临床亚组中的预后作用。
在中位随访 61.9 个月后,我们发现 PNI 与较差的 OS(调整后的危险比 [aHR],1.290;95%置信区间,1.087-1.531)和 DFS(aHR,1.397;95%置信区间,1.207-1.617)相关,与肿瘤分期无关。有趣的是,在 II 期 CRC 患者 OS 和 DFS 风险因素的列线图中,PNI 的权重仅次于不完全切除。此外,PNI 阳性的 II 期患者与 III 期患者的 OS 和 DFS 无显著差异(均 P>0.05)。PNI 也是 III 期 CRC 患者 DFS 的独立预后因素(aHR:1.514;95%置信区间,1.211-1.892)。最后,PNI 对 OS 的不良影响在女性、早发和非糖尿病患者中比在其对应者中更为显著(交互 P=0.0213、0.0280 和 0.0186)。
PNI 是 CRC 的一个重要预后因素,其重要性超过 II 期。伴有神经周围侵犯的 II 期患者的生存与 III 期患者相似。III 期 CRC 中的 PNI 也提示预后更差。